Transmission-focused malaria control in the Asia-Pacific region
Official title: Project 2 - Transmission
Funded at Walter and Eliza Hall Inst Medical Res · NIH-11421423 · Data updated 2026-11-12
Aimed at improving malaria control in the Asia-Pacific region by testing new ways to monitor and counter insecticide resistance and transmission in countries like PNG and Cambodia.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Walter and Eliza Hall Inst Medical Res NIH-funded |
| Lab location | 1 site (Parkville, AUSTRALIA) |
| Project start | April 28, 2017 |
| Project end | March 31, 2029 |
| Funding year | 2026 |
| Award (this year) | $40,817 |
| NIH project number | 5U19AI129392-11 |
| Project ID | NIH-11421423 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are people living in malaria-endemic areas in the Asia-Pacific region, especially communities in PNG and Cambodia where transmission is ongoing.
✕Less likely to help
Communities where malaria transmission is already negligible or where vector control tools are fully effective may see little direct benefit.
What this research studies
This grant supports a multi-site effort to understand how malaria is spreading and how current vector-control tools perform in real-world settings. It builds new methods to track insecticide resistance and to map how mosquitoes move and transmit the disease, with a focus on informing national programs. The work involves partnerships in the Asia-Pacific region, including PNG and Cambodia, and seeks to translate findings into policy and practice that protect communities from malaria. Participants could include health workers and researchers collaborating to strengthen vector-control strategies.
Why it matters
Potential benefit: If successful, the project could improve the effectiveness of malaria control measures and accelerate elimination efforts in high-burden areas.
How similar studies have gone: Similar vector-control and resistance-surveillance approaches have informed policy in some settings, but regional-scale implementation remains challenging and promising.
Where this research is happening
-
Walter and Eliza Hall Inst Medical Res
Parkville, Australia Active
Researchers
- Principal investigator: Mueller, Ivo J — Walter and Eliza Hall Inst Medical Res
- Study coordinator: Mueller, Ivo J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.